GUPTA SHALABH K. (CEO & President) exercised options at UNICYCIVE THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
Common Stock
Shares
+104.61K
Price / share
—
Trade value
—
% of position
Net shares
+104.61K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/11/2023 | M · Option Exercise | +104.61K | — | — | 4.3% | 2.42M | 2.53M |
| Total | +104.61K | $0.00 | ||||||
Series A-1 Convertible Preferred Stock
Common Stock
Shares
−50.00
Strike price
0.49
Held after
0.00
Exercisable
—
Warrant (right to buy
Series A-3 Convertible Preferred Stock
79.25K shares
Shares
+79.25K
Strike price
0.54
Held after
79.25K
Exercisable
—
Warrant (right to buy)
Series A-4 Convertible Preferred Stock
72.05K shares
Shares
+72.05K
Strike price
0.59
Held after
72.05K
Exercisable
—
Warrant (right to buy)
Series A-5 Convertible Preferred Stock
115.28K shares
Shares
+115.28K
Strike price
0.74
Held after
115.28K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A-1 Convertible Preferred Stock Direct | Common Stock | 7/11/2023 | M · Option Exercise | −50.00 | 0.49 | — | 0.00 |
| Warrant (right to buy Direct | Series A-3 Convertible Preferred Stock79.25K shares | 7/11/2023 | M · Option Exercise | +79.25K | 0.54 | — | 79.25K |
| Warrant (right to buy) Direct | Series A-4 Convertible Preferred Stock72.05K shares | 7/11/2023 | M · Option Exercise | +72.05K | 0.59 | — | 72.05K |
| Warrant (right to buy) Direct | Series A-5 Convertible Preferred Stock115.28K shares | 7/11/2023 | M · Option Exercise | +115.28K | 0.74 | — | 115.28K |